Jaguar Health extends crofelemer treatment; launches Neonorm Dog OTC
Jaguar Health says it is extending crofelemer treatment in a multicountry IF safety review and launching Neonorm Dog on Amazon, with broader distribution planned and a Phase 2 SBS-IF start targeted for mid-2027.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.